1-5 of 5
Jennifer Brock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Feasibility, Safety and Efficacy of Oral Maintenance Therapy with Venetoclax Plus Decitabine/Cedazuridine after Venetoclax Plus FluBu2 for High Risk MDS/AML Undergoing RIC Allo-HCT

Jacqueline S. Garcia, Haesook T. Kim, Jennifer Brock, H. Moses Murdock, Mahasweta Gooptu, Vincent T. Ho, Roman M. Shapiro, Christopher J. Gibson, Amar H. Kelkar, Corey S. Cutler, Denbaa Bat-Erdene, Jeremy Ryan, Anna Bosch-Vilaseca, Anthony G. Letai, Jerome Ritz, Coleman Lindsley, Robert J. Soiffer, Joseph Antin
Journal: Blood
Blood (2024) 144 (Supplement 1): 1045.
https://doi.org/10.1182/blood-2024-194170
Published: 2024
Journal Articles

Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study

Jacqueline S. Garcia, Haesook T Kim, Jennifer Brock, H. Moses Murdock, Corey S. Cutler, Daniel J. DeAngelo, Christopher J. Gibson, Mahasweta Gooptu, Vincent Ho, John Koreth, Marlise R. Luskin, Sarah Nikiforow, Rizwan Romee, Roman M Shapiro, Richard M. Stone, Martha Wadleigh, Eric S. Winer, Michela Ansuinelli, Eliza Elliot, Geoffrey Fell, Hannah Karp, Jeremy Ryan, Anthony G. Letai, Coleman Lindsley, Robert J Soiffer, Joseph H. Antin, Fiona Loschi, Jerome Ritz
Journal: Blood
Blood (2022) 140 (Supplement 1): 917–919.
https://doi.org/10.1182/blood-2022-157611
Published: 2022
Journal Articles

Cytokine-Induced Memory-like NK Cells Exhibit Massive Expansion and Long-Term Persistence after Infusion Post-Haploidentical Stem Cell Transplantation: A Report of the First Three Cases in a Phase I Trial

Roman M Shapiro, MD, Sarah Nikiforow, MD PhD, Benedetta Rambaldi, MD, Juliana Vergara, Heather Daley, Haesook T. Kim, PhD, Corey Cutler, MD MPH, FRCPC, Vincent T. Ho, MD, John Koreth, MBBS, DPhil, Mahasweta Gooptu, MD, Joseph H. Antin, MD, Jennifer Brock, Catherine J. Wu, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Rizwan Romee, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-133933
Published: 2020
Journal Articles

Safety and Efficacy of Adding Venetoclax to Reduced Intensity Conditioning Chemotherapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with High Risk Myeloid Malignancies

Jacqueline S. Garcia, MD, Haesook Kim, Corey Cutler, MD MPH, FRCPC, Eric S. Winer, MD, Richard M. Stone, MD, Vincent T. Ho, MD, Rizwan Romee, MD, John Koreth, MBBS, DPhil, Mahasweta Gooptu, MD, Sarah Nikiforow, MD PhD, Roman M Shapiro, MD, David P. Steensma, MD, Marlise R. Luskin, MD, Martha Wadleigh, MD, Fiona Loschi, Jeremy Ryan, Anthony Letai, R. Coleman Lindsley, MD PhD, Jennifer Brock, Robert J. Soiffer, MD, Daniel J. DeAngelo, MD PhD, Joseph H. Antin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-134947
Published: 2020
Journal Articles

A Phase 1 Dose-Escalation Study of Adding Venetoclax to a Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Patients with High Risk Myeloid Malignancies

Jacqueline S Garcia, MD, Haesook T. Kim, PhD, Jennifer Brock, Amy Han, MPH, Jeremy A. Ryan, SM, Thelma Mashaka, BA, Anthony G. Letai, MD PhD, R. Coleman Lindsley, MD PhD, Mahasweta Gooptu, MD, Vincent T. Ho, MD, John Koreth, MBBS, DPhil, Sarah Nikiforow, MD PhD, Rizwan Romee, MD PhD, Ilene Galinsky, Martha Wadleigh, MD, David P. Steensma, MD, Richard M. Stone, MD, Robert J. Soiffer, MD, Corey Cutler, MD MPH, FRCPC, Daniel J. DeAngelo, MD, Joseph H. Antin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 258.
https://doi.org/10.1182/blood-2019-126172
Published: 2019